These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 28893132

  • 41. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
    Reuland EA, Sonder GJ, Stolte I, Al Naiemi N, Koek A, Linde GB, van de Laar TJ, Vandenbroucke-Grauls CM, van Dam AP.
    Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840
    [Abstract] [Full Text] [Related]

  • 42. Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates.
    Afridi FI, Farooqi BJ.
    J Coll Physicians Surg Pak; 2012 Jun; 22(6):358-62. PubMed ID: 22630093
    [Abstract] [Full Text] [Related]

  • 43. Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013.
    Arnaud I, Maugat S, Jarlier V, Astagneau P, National Early Warning, Investigation and Surveillance of Healthcare-Associated Infections Network (RAISIN)/multidrug resistance study group.
    Euro Surveill; 2015 Jun; 20(36):. PubMed ID: 26536042
    [Abstract] [Full Text] [Related]

  • 44. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
    Toner L, Papa N, Aliyu SH, Dev H, Lawrentschuk N, Al-Hayek S.
    World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
    [Abstract] [Full Text] [Related]

  • 45. The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.
    Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Omorogbe J, Dankwa L, Wheeler M, Tolomeo P, Han JH, CDC Prevention Epicenters Program.
    BMC Infect Dis; 2019 Feb 14; 19(1):163. PubMed ID: 30764770
    [Abstract] [Full Text] [Related]

  • 46. Extended-Spectrum Beta-Lactamase-Producing Bacteria in a Urology Ward: Epidemiology, Risk Factors and Antimicrobial Susceptibility Patterns.
    Medina-Polo J, Arrébola-Pajares A, Pérez-Cadavid S, Benítez-Sala R, Sopeña-Sutil R, Lara-Isla A, Alsonso-Isa M, Gil-Moradillo J, Justo-Quintas J, Miranda-Utrera N, Aguilar-Gisbert L, Passas-Martínez JB, Tejido-Sánchez Á.
    Urol Int; 2015 Feb 14; 95(3):288-92. PubMed ID: 26394031
    [Abstract] [Full Text] [Related]

  • 47. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital.
    Strysko JP, Mony V, Cleveland J, Siddiqui H, Homel P, Gagliardo C.
    Travel Med Infect Dis; 2016 Feb 14; 14(6):568-571. PubMed ID: 27890813
    [Abstract] [Full Text] [Related]

  • 48. [Epidemiological profile of uropathogenic enterobacteria producing extended spectrum beta-lactamases].
    Sbiti M, Lahmadi K, Louzi L.
    Pan Afr Med J; 2017 Feb 14; 28():29. PubMed ID: 29138665
    [Abstract] [Full Text] [Related]

  • 49. Pediatric Febrile Urinary Tract Infection Caused by ESBL Producing Enterobacteriaceae Species.
    Agegnehu A, Worku M, Nigussie D, Lulu B, Tadesse BT.
    Biomed Res Int; 2020 Feb 14; 2020():6679029. PubMed ID: 34692824
    [Abstract] [Full Text] [Related]

  • 50. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities.
    Tinelli M, Cataldo MA, Mantengoli E, Cadeddu C, Cunietti E, Luzzaro F, Rossolini GM, Tacconelli E.
    J Antimicrob Chemother; 2012 Dec 14; 67(12):2982-7. PubMed ID: 22865381
    [Abstract] [Full Text] [Related]

  • 51. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital.
    Osthoff M, McGuinness SL, Wagen AZ, Eisen DP.
    Int J Infect Dis; 2015 May 14; 34():79-83. PubMed ID: 25769526
    [Abstract] [Full Text] [Related]

  • 52. Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.
    Augustine MR, Testerman TL, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN.
    Infect Control Hosp Epidemiol; 2017 Mar 14; 38(3):266-272. PubMed ID: 27989244
    [Abstract] [Full Text] [Related]

  • 53. [Antimicrobial susceptibility in urinary tract infections caused by ESBL- and non-ESBL-producing Enterobacteriaceae in hospitalized/outpatient-, sex-, age-matched patients].
    Jaqueti-Aroca J, Molina-Esteban L, Limón-Yelmo A, García-Arata I.
    Rev Esp Quimioter; 2018 Feb 14; 31(1):63-65. PubMed ID: 29390602
    [No Abstract] [Full Text] [Related]

  • 54. [Five years follow-up of infections with extended-spectrum beta-lactamase producing enterobacteriaceae].
    Fouquet M, Morange V, Bruyère F.
    Prog Urol; 2012 Jan 14; 22(1):17-21. PubMed ID: 22196001
    [Abstract] [Full Text] [Related]

  • 55. Extended-spectrum beta-lactamases in urinary tract infections caused by Enterobacteria: understanding and guidelines for action.
    García-Tello A, Gimbernat H, Redondo C, Arana DM, Cacho J, Angulo JC.
    Actas Urol Esp; 2014 Dec 14; 38(10):678-84. PubMed ID: 24984581
    [Abstract] [Full Text] [Related]

  • 56. Trends in Distribution and Antibiotic Resistance of Bacteria Isolated from Urine Cultures of Children in Northern Israel Between 2010 and 2017.
    Graif N, Abozaid S, Peretz A.
    Microb Drug Resist; 2020 Nov 14; 26(11):1342-1349. PubMed ID: 32407193
    [Abstract] [Full Text] [Related]

  • 57. Retrospective assessment of antimicrobial stewardship initiative in outpatient use of ertapenem for uncomplicated extended spectrum beta lactamase Enterobacteriaceae urinary tract infections.
    Wong CP, Delate T, Hudson E, Nguyen JK, Yang SJ, Abraham M.
    BMC Infect Dis; 2021 Aug 16; 21(1):823. PubMed ID: 34399680
    [Abstract] [Full Text] [Related]

  • 58. Molecular epidemiology and antimicrobial resistance pattern of extended-spectrum-β-lactamase-producing Enterobacteriaceae in Glasgow, Scotland.
    Khanna N, Boyes J, Lansdell PM, Hamouda A, Amyes SG.
    J Antimicrob Chemother; 2012 Mar 16; 67(3):573-7. PubMed ID: 22169188
    [Abstract] [Full Text] [Related]

  • 59. Prospective cohort study of risk factors for extended-spectrum ß-lactamase-producing Escherichia coli urinary tract infections in elderly patients admitted to hospital.
    Artero A, Esparcia A, Alberola J, Madrazo M, Nogueira JM, Eiros JM.
    Int J Clin Pract; 2017 Sep 16; 71(9):. PubMed ID: 28873266
    [Abstract] [Full Text] [Related]

  • 60. Managing ESBL-producing Enterobacteriaceae-related urinary tract infection in primary care: a tool kit for general practitioners.
    Zucconi A, Courjon J, Maruéjouls C, Saintpère F, Degand N, Pandiani L, Pradier C, Mondain V.
    Eur J Clin Microbiol Infect Dis; 2018 May 16; 37(5):983-986. PubMed ID: 29594799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.